Randomized controlled trials and real life studies. Approaches and methodologies: a clinical point of view.
Tóm tắt
Từ khóa
Tài liệu tham khảo
Riegelman, 2000
Nallamothu, 2008, Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies, Circulation, 118, 1294, 10.1161/CIRCULATIONAHA.107.703579
Compher, 2010, Efficacy vs effectiveness, JPEN J Parenter Enteral Nutr, 34, 598, 10.1177/0148607110381906
Stanley, 2007, Design of randomized controlled trials, Circulation, 115, 1164, 10.1161/CIRCULATIONAHA.105.594945
Stanley, 2007, Evaluation of randomized controlled trials, Circulation, 115, 1819, 10.1161/CIRCULATIONAHA.106.618603
Price, 2011, Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness, Curr Allergy Asthma Rep, 11, 526, 10.1007/s11882-011-0222-7
Price, 2013, Feasibility and ethics, Am J Respir Crit Care Med, 188, 1368, 10.1164/rccm.201307-1250LE
Roche, 2013, Integrating real-life studies in the global therapeutic research framework, Lancet Respir Med, 1, e29, 10.1016/S2213-2600(13)70199-1
Concato, 2013, Study design and “evidence” in patient-oriented research, Am J Respir Crit Care Med, 187, 1167, 10.1164/rccm.201303-0521OE
Albert, 2013, “Lies, damned lies…” and observational studies in comparative effectiveness research, Am J Respir Crit Care Med, 187, 1173, 10.1164/rccm.201212-2187OE
Nichol, 2010, Challenging issues in randomised controlled trials, Injury, 41, S20, 10.1016/j.injury.2010.03.033
Jaillon, 2007, Controlled randomized clinical trials, Bull Acad Natl Med, 191, 739
Price, 2013, Efficacy versus effectiveness trials: informing guidelines for asthma management, Curr Opin Allergy Clin Immunol, 13, 50, 10.1097/ACI.0b013e32835ad059
US Preventive Services Task Force, 1996
Samet, 2003, Measuring the effectiveness of inhaled corticosteroids for COPD is not easy!, Am J Respir Crit Care Med, 168, 1, 10.1164/rccm.2304004
2008
Reddel, 2009, An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice, Am J Respir Crit Care Med, 180, 59, 10.1164/rccm.200801-060ST
GINA report. Global strategy for asthma management and prevention. Updated December 2012. http://www.ginasthma.org.
Vercken, 1991, Randomized therapeutic trials of community-acquired lung diseases. Analysis of studies published between 1978 and 1988, Rev Pneumol Clin, 47, 21
Altenburg, 2013, Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial, J Am Med Assoc, 309, 1251, 10.1001/jama.2013.1937
McKee, 1999, Methods in health services research: interpreting the evidence: choosing between randomised and non-randomised studies, BMJ, 319, 312, 10.1136/bmj.319.7205.312
Estellat, 2009, How to perform a critical analysis of a randomised controlled trial, Best Pract Res Clin Rheumatol, 23, 291, 10.1016/j.berh.2009.03.003
Wood, 2008, Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study, BMJ, 336, 601, 10.1136/bmj.39465.451748.AD
Hollis, 1999, What is meant by intention to treat analysis? Survey of published randomised controlled trials, BMJ, 319, 670, 10.1136/bmj.319.7211.670
Rothwell, 2005, External validity of randomised controlled trials: “to whom do the results of this trial apply?”, Lancet, 365, 82, 10.1016/S0140-6736(04)17670-8
Annemans L, Aristides M, Kubin M. Real-life data: a growing need. ISPOR; www.ispor.org/news/articles/oct07/rld.asp.
Järvinen, 2011, The true cost of pharmacological disease prevention, BMJ, 342, d2175, 10.1136/bmj.d2175
Krishnan, 2011, A call for action: comparative effectiveness research in asthma, J Allergy Clin Immunol, 127, 123, 10.1016/j.jaci.2010.08.032
Ware, 2011, Pragmatic trials – guides to better patient care?, N Engl J Med, 364, 1685, 10.1056/NEJMp1103502
Herland, 2005, How representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease?, Respir Med, 99, 11, 10.1016/j.rmed.2004.03.026
Scichilone, 2013, What proportion of Chronic Obstructive Pulmonary Disease outpatients is eligible for inclusion in randomized clinical trials?, Respiration
Haughney, 2008, Achieving asthma control in practice: understanding the reasons for poor control, Respir Med, 102, 1681, 10.1016/j.rmed.2008.08.003
Corrigan, 2011, Asthma therapy: there are guidelines, and then there is real life, Prim Care Respir J, 20, 13, 10.4104/pcrj.2011.00016
Lötvall, 2011, Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome, J Allergy Clin Immunol, 127, 355, 10.1016/j.jaci.2010.11.037
Rand, 2012, Mediators of asthma outcomes, J Allergy Clin Immunol, 129, S136, 10.1016/j.jaci.2011.12.987
Smith, 2012, The at-risk registers in severe asthma (ARRISA) study: a cluster-randomised controlled trial examining effectiveness and costs in primary care, Thorax, 67, 1052, 10.1136/thoraxjnl-2012-202093
Chaudhuri, 2003, Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma, Am J Respir Crit Care Med, 168, 1308, 10.1164/rccm.200304-503OC
Tomlinson, 2005, Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma, Thorax, 60, 282, 10.1136/thx.2004.033688
Lange, 1998, A 15-year follow-up study of ventilatory function in adults with asthma, N Engl J Med, 339, 1194, 10.1056/NEJM199810223391703
Chaudhuri, 2006, Effects of smoking cessation on lung function and airway inflammation in smokers with asthma, Am J Respir Crit Care Med, 174, 127, 10.1164/rccm.200510-1589OC
Eisner, 2007, The influence of cigarette smoking on adult asthma outcomes, Nicotine Tob Res, 9, 53, 10.1080/14622200601078293
Boulet, 2008, Influence of current or former smoking on asthma management and control, Can Respir J, 15, 275, 10.1155/2008/725074
Krishnan, 2008, Hospitalizations for asthma in the elderly in the U.S. in 2000 and 2005, Am J Respir Crit Care Med, 177
National Institutes of Health, National Heart Lung and Blood Institute. Morbidity & mortality: 2009 chart book on cardiovascular, lung, and blood diseases. http://www.nhlbi.nih.gov/resources/docs/2009_ChartBook.pdf.
Moore, 2010, Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program, Am J Respir Crit Care Med, 181, 315, 10.1164/rccm.200906-0896OC
Ozyilmaz, 2013, Unsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary disease, Int J Clin Pract, 67, 691, 10.1111/ijcp.12150
Fabbri, 2012, How to integrate multiple comorbidities in guideline development: article 10 in integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report, Proc Am Thorac Soc, 9, 274, 10.1513/pats.201208-063ST
Peters-Golden, 2006, Influence of body mass index on the response to asthma controller agents, Eur Respir J, 27, 495, 10.1183/09031936.06.00077205
Hawkins, 2010, Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme, Eur J Heart Fail, 12, 557, 10.1093/eurjhf/hfq040
Brooks, 2007, Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers, Pharmacotherapy, 27, 684, 10.1592/phco.27.5.684
Kunz, 1998, The unpredictability paradox: review of empirical comparisons of randomised and nonrandomised clinical trials, BMJ, 317, 1185, 10.1136/bmj.317.7167.1185
Giraud, 2002, Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability, Eur Respir J, 19, 246, 10.1183/09031936.02.00218402
Davies, 1994, Effect of nonattenders on the potential of a primary care programme to reduce cardiovascular risk in the population, BMJ, 309, 1553, 10.1136/bmj.309.6968.1553
Hunninghake, 1987, Recruitment experience in clinical trials: literature summary and annotated bibliography, Control Clin Trials, 8, 6S, 10.1016/0197-2456(87)90004-3
Horwitz, 1987, Complexity and contradiction in clinical trial research, Am J Med, 82, 498, 10.1016/0002-9343(87)90450-5
Colditz, 1994, Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature, J Am Med Assoc, 271, 698, 10.1001/jama.1994.03510330076038
Clemens, 1983, The BCG controversy. A methodological and statistical reappraisal, J Am Med Assoc, 249, 2362, 10.1001/jama.1983.03330410048027
Wechsler, 2011, Active albuterol or placebo, sham acupuncture, or no intervention in asthma, N Engl J Med, 365, 119, 10.1056/NEJMoa1103319
Ryan, 2012, Clinical and cost effectiveness of mobile phone supported self monitoring of asthma: multicentre randomised controlled trial, BMJ, 344, e1756, 10.1136/bmj.e1756
Konstantinou, 2012, Pragmatic trials: how to adjust for the ‘Hawthorne effect’?, Thorax, 67, 562, 10.1136/thoraxjnl-2011-200657
Baiardini, 2009, Why do doctors and patients not follow guidelines?, Curr Opin Allergy Clin Immunol, 9, 228, 10.1097/ACI.0b013e32832b4651
Pauwels, 1997, Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group, N Engl J Med, 337, 1405, 10.1056/NEJM199711133372001
Bjermer, 2003, Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial, BMJ, 327, 891, 10.1136/bmj.327.7420.891
Bateman, 2004, Can guideline-defined asthma control be achieved? the gaining optimal asthma control study, Am J Respir Crit Care Med, 170, 836, 10.1164/rccm.200401-033OC
Feudtner, 2013, Risks (and benefits) in comparative effectiveness research trials, N Engl J Med, 369, 892, 10.1056/NEJMp1309322
Barnes, 2013, Effectiveness of omalizumab in severe allergic asthma: a retrospective UK real-world study, J Asthma, 50, 529, 10.3109/02770903.2013.790419
Folli, 2012, COPD treatment: real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion, Pulm Pharmacol Ther, 25, 371, 10.1016/j.pupt.2012.06.009
Öztürk, 2012, Evaluation of inhaler technique and patient satisfaction with fixed-combination budesonide/formoterol dry-powder inhaler in chronic obstructive pulmonary disease (COPD): data on real-life clinical practice in Turkey, Tuberk Torak, 60, 301, 10.5578/tt.4634
Bourbeau, 2013, Making collaborative self-management successful in COPD patients with high disease burden, Respir Med, 107, 1061, 10.1016/j.rmed.2013.03.003
Braido, 2013, International cross-sectional and longitudinal assessment on asthma control in European adult patients – the LIAISON study protocol, BMC Pulm Med, 13, 18, 10.1186/1471-2466-13-18
Price, 2013, A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use, Appl Health Econ Health Policy, 11, 259, 10.1007/s40258-013-0021-5
Scichilone, 2013, Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations, J Asthma Allergy, 6, 11, 10.2147/JAA.S14743
van Nooten, 2013, Cost-effectiveness of omalizumab for uncontrolled allergic asthma in the Netherlands, J Med Econ, 16, 342
Tunis, 2003, Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy, J Am Med Assoc, 290, 1624, 10.1001/jama.290.12.1624
Zwarenstein, 2008, Improving the reporting of pragmatic trials: an extension of the CONSORT statement, BMJ, 337, a2390, 10.1136/bmj.a2390
Chalkidou, 2012, The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research, Clin Trials, 9, 436, 10.1177/1740774512450097
Sarrazin, 2012, Finding pure and simple truths with administrative data, J Am Med Assoc, 307, 1433, 10.1001/jama.2012.404
Di Marco, 2013, Chronic obstructive pulmonary disease diagnosis: the simpler the better? Not always, Eur J Intern Med, 24, 199, 10.1016/j.ejim.2013.01.008
Bombardier, 1999, Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?, Ann Rheum Dis, 58, I82, 10.1136/ard.58.2008.i82
Concato, 2000, Randomized, controlled trials, observational studies, and the hierarchy of research designs, N Engl J Med, 342, 1887, 10.1056/NEJM200006223422507
Rabe, 2004, Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys, Allergy Clin Immunol, 114, 40, 10.1016/j.jaci.2004.04.042
Melani, 2011, Inhaler mishandling remains common in real life and is associated with reduced disease control, Respir Med, 105, 930, 10.1016/j.rmed.2011.01.005
Brocklebank, 2001, Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature, Health Technol Assess, 5, 1, 10.3310/hta5260
Dolovich, 2005, Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology, Chest, 127, 335, 10.1378/chest.127.1.335
National Asthma Education And Prevention Program, 2007
Papi, 2011, Inhaler devices for asthma: a call for action in a neglected field, Eur Respir J, 37, 982, 10.1183/09031936.00150910
Price, 2012, Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care, Allergy Asthma Immunol Res, 4, 184, 10.4168/aair.2012.4.4.184
Price, 2011, Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD, J Asthma Allergy, 4, 37
Price, 2011, Device type and real-world effectiveness of asthma combination therapy: an observational study, Respir Med, 105, 1457, 10.1016/j.rmed.2011.04.010
Müller, 2011, Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation, BMC Pulm Med, 11, 40, 10.1186/1471-2466-11-40
Santus, 2012, Doctor-patient relationship: a resource to improve respiratory diseases management, Eur J Intern Med, 23, 442, 10.1016/j.ejim.2012.04.004
Price, 2010, Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study, BMC Pulm Med, 10, 1, 10.1186/1471-2466-10-1
Price, 2011, Leukotriene antagonists as first-line or add-on asthma-controller therapy, N Engl J Med, 364, 1695, 10.1056/NEJMoa1010846
Ducharme, 2012, Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors, Curr Med Res Opin, 28, 111, 10.1185/03007995.2011.640668
van Staa, 2009, A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example, PLoS Med, 6, e1000194, 10.1371/journal.pmed.1000194
Rizzo, 1999, Methodological hurdles in conducting pharmacoeconomic studies, Pharmacoeconomics, 15, 339, 10.2165/00019053-199915040-00002
Stempel, 2004, Treatment patterns in the months prior to and after asthma-related emergency department visit, Chest, 126, 75, 10.1378/chest.126.1.75
Molimard, 2003, Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care, Aerosol Med, 16, 249, 10.1089/089426803769017613
Austin, 2007, A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study, Stat Med, 26, 734, 10.1002/sim.2580
Thomas, 2003, Database studies in asthma pharmacoeconomics: uses, limitations and quality markers, Expert Opin Pharmacother, 4, 351, 10.1517/14656566.4.3.351
Resch, 2005, Pragmatic trials: propaganda or research tool?, Focus Altern Complement Ther, 10, 181, 10.1211/fact.10.3.0006
Kent, 2009, Against pragmatism: on efficacy, effectiveness and the real world, Trials, 10, 48, 10.1186/1745-6215-10-48
Haut, 2011, Surveillance bias in outcomes reporting, J Am Med Assoc, 305, 2462, 10.1001/jama.2011.822
Pierce, 2008, Surveillance bias and deep vein thrombosis in the National Trauma Data Bank: the more we look, the more we find, J Trauma, 64, 932
Salas, 1999, Confounding by indication: an example of variation in the use of epidemiologic terminology, Am J Epidemiol, 149, 981, 10.1093/oxfordjournals.aje.a009758
Hennekens, 1987, 272
Blais, 1996, Confounding by indication and channeling over time: the risks of beta2-agonists, Am J Epidemiol, 144, 1161, 10.1093/oxfordjournals.aje.a008895
Kozyrskyj, 2007, Increased risk of childhood asthma from antibiotic use in early life, Chest, 131, 1753, 10.1378/chest.06-3008
Alm, 2008, Neonatal antibiotic treatment is a risk factor for early wheezing, Pediatrics, 121, 697, 10.1542/peds.2007-1232
Almqvist, 2012, Antibiotics and asthma medication in a large register-based cohort study - confounding, cause and effect, Clin Exp Allergy, 42, 104, 10.1111/j.1365-2222.2011.03850.x
Heintze, 2013, The case of drug causation of childhood asthma: antibiotics and paracetamol, Eur J Clin Pharmacol, 69, 1197, 10.1007/s00228-012-1463-7
Cullinan, 2004, Early prescriptions of antibiotics and the risk of allergic disease in adults: a cohort study, Thorax, 59, 11
Sin, 2001, Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 164, 580, 10.1164/ajrccm.164.4.2009033
Suissa, 2003, Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies, Am J Respir Crit Care Med, 168, 49, 10.1164/rccm.200210-1231OC
Horwitz, 1990, Developing improved observational methods for evaluating therapeutic effectiveness, Am J Med, 89, 6308, 10.1016/0002-9343(90)90182-D
von Elm, 2007, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, Lancet, 370, 1453, 10.1016/S0140-6736(07)61602-X
Begg, 1996, Improving the quality of reporting of randomized controlled trials. The CONSORT statement, J Am Med Assoc, 276, 637, 10.1001/jama.1996.03540080059030
Campbell, 2004, CONSORT statement: extension to cluster randomised trials, BMJ, 328, 702, 10.1136/bmj.328.7441.702
Campbell, 2012, Consort 2010 statement: extension to cluster randomised trials, BMJ, 345, e5661, 10.1136/bmj.e5661
Perkins, 2000, The use of propensity scores in pharmacoepidemiologic research, Pharmacoepidemiol Drug Saf, 9, 93, 10.1002/(SICI)1099-1557(200003/04)9:2<93::AID-PDS474>3.0.CO;2-I
Newgard, 2004, Advanced statistics: the propensity score – a method for estimating treatment effect in observational research, Acad Emerg Med, 11, 953, 10.1197/j.aem.2004.02.530
Rosenbaum, 1983, The central role of the propensity score in observational studies for causal effects, Biometrika, 70, 41, 10.1093/biomet/70.1.41
Rosenbaum, 1984, Reducing bias in observational studies using subclassification on the propensity score, J Am Stat Assoc, 79, 516, 10.1080/01621459.1984.10478078
D’Agostino, 1998, Tutorial in biostatistics – propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group, Stat Med, 17, 2265, 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
Little, 2000, Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches, Annu Rev Public Health, 21, 121, 10.1146/annurev.publhealth.21.1.121
Rubin, 1997, Estimating causal effects from large data sets using propensity scores, Ann Intern Med, 127, 757, 10.7326/0003-4819-127-8_Part_2-199710151-00064
Heinze, 2011, An overview of the objectives of and the approaches to propensity score analyses, Eur Heart J, 32, 1704, 10.1093/eurheartj/ehr031
Barnes, 2011, Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study, Clin Exp Allergy, 41, 1521, 10.1111/j.1365-2222.2011.03820.x